pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,867 catalysts · 4,970 phase readout · 2,331 8k filing · 283 earnings · 277 pdufa · 115 phase 2 completion · 53 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 17 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout4,970
  • 8k filing2,331
  • earnings283
  • pdufa277
  • phase 2 completion115
  • phase 1 completion53
  • phase 1 2 completion28
  • phase 1 initiation26
  • phase 0 trial completion22
  • phase 1 2 initiation9
  • therapy area
    • Oncology98
    • Cardiology26
    • Immunology17
    • Infectious Disease16
    • Dermatology13
    • Pulmonology11
    • Ophthalmology10
    • Women's Health9
    • Pain7

    Week of Jul 20, 2026

    1
    ›Jul 24, 20268k filing5d ago$LITS — Lite Strategy, Inc. (LITS) — 8-K filing

    Items: 7.01

    full page →edgar 8k ↗

    Week of Jul 27, 2026

    42
    ›07/27/2026adcom2d agoAdvisory Committee Calendar

    This page contains notices of advisory committee meetings. Refer to the individual meeting link below for more information on the anticipated format of each meeting. For previous years' advisory committee calendars, see the FDA Archive.

    full page →fda adcom ↗
    ›Jul 27, 20268k filing2d agoProfusa, Inc. (PFSA, NVACW) — 8-K filing

    Items: 5.02, 7.01, 8.01, 9.01

    full page →edgar 8k ↗
    ›Jul 27, 20268k filing2d ago$FBRX — Forte Biosciences, Inc. (FBRX) — 8-K filing

    Items: 1.01, 7.01, 9.01

    full page →edgar 8k ↗
    ›Jul 27, 20268k filing2d ago$CAMP — Camp4 Therapeutics Corp (CAMP) — 8-K filing

    Items: 7.01, 8.01, 9.01

    full page →edgar 8k ↗
    ›Jul 27, 20268k filing2d ago$MPLT — MapLight Therapeutics, Inc. (MPLT) — 8-K filing

    Items: 7.01, 8.01, 9.01

    full page →edgar 8k ↗
    ›Jul 27, 20268k filing2d ago$NMRA — Neumora Therapeutics, Inc. (NMRA) — 8-K filing

    Items: 8.01, 9.01

    full page →edgar 8k ↗
    ›Jul 27, 20268k filing2d ago$DTIL — PRECISION BIOSCIENCES INC (DTIL) — 8-K filing

    Items: 5.02, 7.01, 9.01

    full page →edgar 8k ↗
    ›Jul 27, 20268k filing2d ago$CTMX — CytomX Therapeutics, Inc. (CTMX) — 8-K filing

    Items: 5.02

    full page →edgar 8k ↗
    ›Jul 27, 20268k filing2d ago$SPRB — SPRUCE BIOSCIENCES, INC. (SPRB) — 8-K filing

    Items: 5.02

    full page →edgar 8k ↗
    ›Jul 27, 20268k filing2d ago$KYTX — Kyverna Therapeutics, Inc. (KYTX) — 8-K filing

    Items: 1.01, 7.01, 9.01

    full page →edgar 8k ↗
    ›Jul 27, 20268k filing2d agobioAffinity Technologies, Inc. (BIAF, BIAFW) — 8-K filing

    Items: 8.01, 9.01

    full page →edgar 8k ↗
    ›Jul 27, 20268k filing2d ago$JUNS — JUPITER NEUROSCIENCES, INC. (JUNS) — 8-K filing

    Items: 5.07, 8.01, 9.01

    full page →edgar 8k ↗
    ›Jul 27, 20268k filing2d ago$PMI — Picard Medical, Inc. (PMI) — 8-K filing

    Items: 3.01, 8.01, 9.01

    full page →edgar 8k ↗
    ›Jul 27, 20268k filing2d ago$SRPT — Sarepta Therapeutics, Inc. (SRPT) — 8-K filing

    Items: 5.02, 7.01, 9.01

    full page →edgar 8k ↗
    ›Jul 27, 20268k filing2d ago$VREOF — Vireo Growth Inc. (VREOF) — 8-K filing

    Items: 8.01, 9.01

    full page →edgar 8k ↗
    ›Jul 27, 20268k filing2d agoPetVivo Holdings, Inc. (PETV, PETVW) — 8-K filing

    Items: 4.01, 9.01

    full page →edgar 8k ↗
    ›Jul 27, 20268k filing2d ago$GOSS — Gossamer Bio, Inc. (GOSS) — 8-K filing

    Items: 1.01, 1.02, 2.02, 7.01, 8.01, 9.01

    full page →edgar 8k ↗
    ›Jul 27, 20268k filing2d agoFOXO TECHNOLOGIES INC. (FOXO, FOXOD, FOXOW) — 8-K filing

    Items: 1.01, 9.01

    full page →edgar 8k ↗
    ›Jul 27, 20268k filing2d ago$KYMR — Kymera Therapeutics, Inc. (KYMR) — 8-K filing

    Items: 5.02, 7.01, 9.01

    full page →edgar 8k ↗
    ›Jul 27, 20268k filing2d ago$OPK — OPKO HEALTH, INC. (OPK) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Jul 27, 20268k filing2d ago$APVO — Aptevo Therapeutics Inc. (APVO) — 8-K filing

    Items: 8.01, 9.01

    full page →edgar 8k ↗
    ›Jul 27, 20268k filing2d ago$BSX — BOSTON SCIENTIFIC CORP (BSX) — 8-K filing

    Items: 2.05

    full page →edgar 8k ↗
    ›Jul 27, 20268k filing2d ago$CSBR — CHAMPIONS ONCOLOGY, INC. (CSBR) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Jul 27, 20268k filing2d ago$GCTK — Glucotrack, Inc. (GCTK) — 8-K filing

    Items: 1.01, 2.03, 3.02, 9.01

    full page →edgar 8k ↗
    ›Jul 27, 20268k filing2d ago$GOVX — GeoVax Labs, Inc. (GOVX) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Jul 27, 20268k filing2d ago$SLS — SELLAS Life Sciences Group, Inc. (SLS) — 8-K filing

    Items: 2.02, 8.01, 9.01

    full page →edgar 8k ↗
    ›Jul 27, 20268k filing2d ago$CODX — Co-Diagnostics, Inc. (CODX) — 8-K filing

    Items: 1.01, 9.01

    full page →edgar 8k ↗
    ›Jul 27, 20268k filing2d ago$OWPC — One World Products, Inc. (OWPC) — 8-K filing

    Items: 5.02

    full page →edgar 8k ↗
    ›Jul 27, 20268k filing2d ago$SCTX — Scribe Therapeutics, Inc. (SCTX) — 8-K filing

    Items: 5.03, 9.01

    full page →edgar 8k ↗
    ›Jul 28, 20268k filing1d ago$DNLI — Denali Therapeutics Inc. (DNLI) — 8-K filing

    Items: 2.01, 9.01

    full page →edgar 8k ↗
    ›Jul 28, 20268k filing1d ago$PMN — ProMIS Neurosciences Inc. (PMN) — 8-K filing

    Items: 7.01, 8.01, 9.01

    full page →edgar 8k ↗
    ›Jul 28, 20268k filing1d ago$JNJ — JOHNSON & JOHNSON (JNJ) — 8-K filing

    Items: 7.01, 9.01

    full page →edgar 8k ↗
    ›Jul 28, 20268k filing1d ago$IQV — IQVIA HOLDINGS INC. (IQV) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Jul 28, 20268k filing1d ago$ALT — Altimmune, Inc. (ALT) — 8-K filing

    Items: 7.01, 8.01, 9.01

    full page →edgar 8k ↗
    ›Jul 28, 20268k filing1d ago$RGEN — REPLIGEN CORP (RGEN) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Jul 28, 20268k filing1d ago$ALKS — Alkermes plc. (ALKS) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Jul 28, 20268k filing1d ago$GRCE — Grace Therapeutics, Inc. (GRCE) — 8-K filing

    Items: 8.01, 9.01

    full page →edgar 8k ↗
    ›Jul 28, 20268k filing1d ago$INCY — INCYTE CORP (INCY) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Jul 28, 20268k filing1d ago$KNSA — Kiniksa Pharmaceuticals International, plc (KNSA) — 8-K filing

    Items: 2.02, 9.01

    full page →edgar 8k ↗
    ›Jul 28, 20268k filing1d ago$INFU — InfuSystem Holdings, Inc (INFU) — 8-K filing

    Items: 7.01

    full page →edgar 8k ↗
    ›Jul 28, 20268k filing1d ago$VXRT — Vaxart, Inc. (VXRT) — 8-K filing

    Items: 8.01

    full page →edgar 8k ↗
    ›Jul 28, 20268k filing1d ago$TTRX — Turn Therapeutics Inc. (TTRX) — 8-K filing

    Items: 7.01, 9.01

    full page →edgar 8k ↗

    Week of Jan 4, 2027

    1
    ›Jan 4, 2027pdufa159dPDUFA — 2027-01-04

    action date of January 4, 2027

    full page →pdufa extract ↗

    Week of Jan 18, 2027

    1
    ›Jan 21, 2027pdufa176dPDUFA — 2027-01-21

    action date of Jan. 21, 2027

    full page →pdufa extract ↗

    Date TBD

    5
    ›TBDapprovalOZURDEX (DEXAMETHASONE) — FDA approvaldexamethasone LA

    Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL

    full page →dexamethasone LA →fda approvals ↗
    ›TBDapproval
    ← prev
    page 58 of 158
    next →
    TRILEPTAL (OXCARBAZEPINE) — FDA approvalOXCARBAZEPINE

    Sponsor: NOVARTIS. Form: TABLET. Route: ORAL

    full page →OXCARBAZEPINE →fda approvals ↗
    ›RECRUITINGphase readoutNCT06924671: GLA:D Back Canada - a Program for Chronic and Persistent Low Back Pain

    Sponsor: University of Alberta. Phase: . Conditions: Low Back Pain

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07542236: Hip and Ankle Mobility Rehabilitation for Soccer Players With Patellofemoral Pain

    Sponsor: Beijing Sport University. Phase: NA. Conditions: Patellofemoral Pain

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06941844: A Phase 3 Trial of MM120 for Major Depressive Disorder (Emerge)Definium Therapeutics, Inc.

    Sponsor: Definium Therapeutics US, Inc.. Phase: PHASE3. Conditions: Major Depressive Disorder

    full page →ctgov ↗
    $ABBV256.91-0.94%
    $NVS156.11+0.71%
    $DFTX